Iovance Biotherapeutics, Inc. (IOVA)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $8.04
- As of
Kresmion compiles this page from IOVA's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
IOVANCE BIOTHERAPEUTICS, INC. (IOVA): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-05.
See the full IOVA dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for IOVA on one page. Preview it with sample data, then open it live with a free account.
Preview the IOVA dossierActive events for IOVA
- mediumEarnings above estimates
Q3-2026: Beat consensus by 42.6%, EPS $-0.05 vs $-0.0871 estimate
- high13F: large increase
CITADEL ADVISORS LLC added +220% to IOVA (2026Q2)
- high13F: large reduction
D. E. Shaw & Co., Inc. cut 73% of IOVA (2026Q2)
- mediumEarnings above estimates
Q2-2026: Beat consensus by 14.5%, EPS $-0.11 vs $-0.1287 estimate
- high13F: funds added
3 tracked funds increased IOVA this 2026Q1 - institutional consensus
FREE, NO ACCOUNT
Every event on IOVA, as it fires
You are seeing 5 of 11 events recorded on IOVA since 2026-05-29.
The five above landed across 4 days. The other 6 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
IOVA positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| TWO SIGMA INVESTMENTS, LP FundCUSIP 462260100 · 2026Q2 | $79.1M | 0.06% |
| MILLENNIUM MANAGEMENT LLC FundCUSIP 462260100 · 2026Q2 | $35.5M | 0.02% |
| D. E. Shaw & Co., Inc. FundCUSIP 462260100 · 2026Q2 | $8.9M | 0.01% |
| CITADEL ADVISORS LLC FundCUSIP 462260100 · 2026Q2 | $8.8M | 0.01% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, IOVA
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
More data on IOVA
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in IOVA on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on IOVA in the last 180 days.
Upstream: SEC EDGAR filings for IOVA
Kresmion, "IOVANCE BIOTHERAPEUTICS, INC. (IOVA) institutional holdings and SEC filings", data as of 2026-11-05, https://kresmion.com/research/IOVA. Upstream data: SEC EDGAR filings for IOVA.
Link to this data (HTML):
<a href="https://kresmion.com/research/IOVA">IOVANCE BIOTHERAPEUTICS, INC. (IOVA) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow IOVA on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to IOVA for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.